Quarterly Result11 Feb 2026, 01:53 pm
Amanta Healthcare Ltd Reports 51% YoY Profit Growth in 9MFY26, Despite Major Capacity Expansion
AI Summary
Amanta Healthcare Limited announced its unaudited financial results for the quarter ended December 31, 2025. The company reported a 9.8% YoY growth in Q3FY26 revenue, which stood at INR 75 cr, and a 3.97% YoY increase in 9MFY26 revenue, reaching INR 211 cr. Operational EBITDA for Q3FY26 was INR 15 cr with margins at 20.62%, while 9MFY26 EBITDA increased 6.06% YoY to INR 45 cr. Net Profit for Q3FY26 rose to INR 5 cr, up 8.1% YoY, while 9MFY26 PAT grew 51.3% YoY to INR 9 cr. The company is executing a focused growth roadmap driven by wallet share expansion in complex therapies, scaling high-margin SteriPort and SVP capacities, and structural cost optimization through green energy initiatives.
Key Highlights
- Sustained revenue trajectory with Q3FY26 revenue at INR 75 cr, up 9.8% YoY, and 9MFY26 revenue at INR 211 cr, up 3.97% YoY.
- Operational EBITDA for Q3FY26 at INR 15 cr with margins at 20.62%, and 9MFY26 EBITDA at INR 45 cr, up 6.06% YoY.
- Net Profit for Q3FY26 rose to INR 5 cr, up 8.1% YoY, and 9MFY26 PAT grew 51.3% YoY to INR 9 cr.
- Improving earnings quality reflected in margins: Q3FY26 PAT margin at 6.21%, and 9MFY26 PAT margin expanded by 139 bps YoY to 4.43%.
- Company is executing a focused growth roadmap for accelerated growth from Q4 onwards.